ORLANDO, Fla., Nov.22, 2025 /PRNewswire/ — This November at the ACAAI Annual Meeting 2025 one theme dominated the conversations: AI reshaping the future of allergy care. mdc mdc-link–bodymdc”>ModuleMD stood out as a clear frontrunner, showcasing a suite of intelligent, specialty-focused technologies built to transform clinical efficiency and elevate the way allergists deliver care.
ModuleMD is not just another EHR; it’s the industry’s leading allergy technology platform, engineered from the ground up to meet the real-world needs of allergists. Unlike generic systems that force clinicians to adapt their workflows, ModuleMD brings purposeful innovation to every step of allergy and immunology practice.
At the centre of ModuleMD’s presence was SkinSight AI,an AI-based clinical decision-support tool that gives allergists objective,standardized data to guide treatment decisions with confidence.
SkinSight AI activates the moment a provider orders and administers a skin test panel. Once the panel is placed, the system analyzes a captured image and automatically detects all positive reactions, providing precise wheal and flare measurements for each allergen. This eliminates manual variability, reduces the burden of interpretation, and dramatically accelerates documentation.
Clinicians gain immediate clarity into which allergens are reacting and the strength of those reactions. With results flowing directly into the patient chart, SkinSight AI transforms a once time-consuming, subjective process into a fast, consistent, and standardized workflow.
current capabilities of SkinSight AI showcased at ACAAI included:
* Automatic detection of positive skin test reactions
* Precise wheal and flare measurement for each allergen
* Instant documentation directly into the chart
* Support for intradermal test standardization
* Fast, clear visibility into reacting allergens
Future enhancements include:
* Tracking changes in reactions across multiple visits
* Showing enhancement or worsening over the course of immunotherapy
* Enabling patients to view their outcomes, which helps drive better adherence and compliance
Alongside SkinSight AI, ModuleMD
ModuleMD Showcases AI-Driven Allergy Solutions at ACAAI 2025
ModuleMD is positioned as a leader in allergy and immunology technology, as demonstrated by its showcase at the American college of Allergy, Asthma & Immunology (ACAAI) 2025 conference. The company’s suite of AI-powered tools, including SkinSight AI, JOSH, SPOCK, and InDrA, are designed to streamline workflows, improve documentation, and enhance patient care for allergists.
According to a press release issued by ModuleMD Healthcare Solutions Private Limited, SkinSight AI is at the forefront of their offerings. Complementary tools like JOSH (an AI-EHR), SPOCK, and InDrA (an inventory management tool) integrate to support allergists across all aspects of their practice.
modulemd aims to empower allergists to work more efficiently and deliver exceptional care in an increasingly technology-driven healthcare landscape.
Join the Community: YouTube
Logo: ModuleMD Logo
Source: ModuleMD Healthcare Solutions Private Limited.